Psychiatry and Neurology, Neurology · Houston, TX
NPI
1619270576
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
6560 Fannin St, Suite 802
Houston, TX, 77030
Phone (713) 363-7345
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
762 services
Medicare patients, 2024
285
Average age 73
Drug cost, 2024
$4.9M
869 prescriptions
Company payments, 2025
$40K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sheetal Shroff was code 99215 (office e&m - established), 192 times for 134 patients. In total Sheetal Shroff billed 762 services in 29 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 192 | 134 | $129.11 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 175 | 77 | $92.82 | $16K |
| 95886 Electrical Nerve Conductivity | Office | 112 | 42 | $73.09 | $8,186 |
| 99223 Hospital E&M - Initial | Facility | 63 | 60 | $138.20 | $8,707 |
| 95913 Electrical Nerve Conductivity | Office | 32 | 32 | $216.75 | $6,936 |
| 99205 Office E&M - New | Office | 25 | 25 | $164.55 | $4,114 |
| 99215 Office E&M - Established | Facility | 21 | 21 | $109.48 | $2,299 |
| 99214 Office E&M - Established | Office | 12 | 12 | $102.67 | $1,232 |
| 99443 Telephone Services | Office | 11 | 11 | $90.73 | $998 |
By year: 2022 $91K for 831 services; 2023 $86K for 781 services; 2024 $82K for 762 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sheetal Shroff prescribed most often to Medicare patients was Gabapentin, with 92 prescriptions and refills. In total Sheetal Shroff wrote 869 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 92 | 201 | 24 | $3,179 |
| Duloxetine Hcl Generic | 74 | 173 | 23 | $1,808 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 63 | 63 | Under 11 | $466K |
| Pyridostigmine Bromide Generic | 58 | 149 | 22 | $4,469 |
| Mycophenolate Mofetil Generic | 51 | 138 | 15 | $9,570 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 45 | 45 | Under 11 | $399K |
| Radicava Ors Edaravone | 41 | 41 | Under 11 | $614K |
| Firdapse Amifampridine Phosphate | 37 | 37 | Under 11 | $886K |
| Azathioprine Generic | 36 | 104 | 13 | $1,798 |
| Riluzole Generic | 26 | 77 | 11 | $3,693 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 26 | 26 | Under 11 | $160K |
| Pregabalin Generic | 25 | 47 | Under 11 | $1,001 |
| Baclofen Generic | 19 | 55 | Under 11 | $488 |
| Prednisone Generic | 18 | 40 | Under 11 | $253 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 17 | 21 | Under 11 | $25K |
Brand drugs: 312 claims; generic drugs: 557 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sheetal Shroff $40K ($40K in general payments such as food, travel and fees) from 15 companies. The largest payer was UCB, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 22 | $14K |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $14K |
| Argenx US, Inc. ARGX | 15 | $12K |
| Tanabe Pharma America, Inc. | 6 | $128 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $96.4 |
| Hospira, Inc. PFE | 3 | $66.23 |
| Biogen, Inc. BIIB | 2 | $45.3 |
| Janssen Biotech, Inc. JNJ | 1 | $44.97 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $43.03 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $25.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.